DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Withdrawn

Conditions: Colorectal Cancer
Rectal Cancer

First Posted Date: 2022-05-02

Last Posted Date: 2024-04-12

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT05356585

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Ductal Adenocarcinoma
Periampullary Cancer

Interventions: Other: Placebo
Drug: Escitalopram

First Posted Date: 2022-03-21

Last Posted Date: 2024-06-18

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 4

Registration Number: NCT05289830

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms

Not Applicable

Conditions: Periampullary Carcinoma
Pancreatic Neoplasms

Interventions: Behavioral: Behavioral Medicine
Other: Exercise
Dietary Supplement: Nutritional
Behavioral: Smoking Cessation

First Posted Date: 2022-02-04

Last Posted Date: 2024-01-08

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT05225038

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Phase 1

Recruiting

Conditions: Relapsed Sarcomas

Interventions: Drug: Disulfiram
Drug: Copper Gluconate
Drug: Liposomal Doxorubicin (Doxil)

First Posted Date: 2022-01-27

Last Posted Date: 2025-03-25

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 24

Registration Number: NCT05210374

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma

Phase 1

Recruiting

Conditions: Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Cancer

Interventions: Drug: Ivosidenib
Drug: mFOLFIRINOX

First Posted Date: 2022-01-26

Last Posted Date: 2024-07-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 16

Registration Number: NCT05209074

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Not Applicable

Active, not recruiting

Conditions: Lung Cancer
Left Sided Breast Cancer

Interventions: Device: Continuous Positive Airway Pressure
Other: Deep inspiratory breath hold
Other: Free Breath

First Posted Date: 2021-12-02

Last Posted Date: 2025-04-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 8

Registration Number: NCT05142358

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Not Applicable

Not yet recruiting

Conditions: Cutaneous T-cell Lymphoma
Mycosis Fungoides of Skin (Diagnosis)
Non Hodgkin Lymphoma
Lymphomatoid Papulosis
Lymphoma, Large-Cell, Anaplastic
Lymphoma, Follicular

Interventions: Device: Med-Jet Injector
Drug: Triamcinolone Acetonide
Device: Conventional syringe
Drug: Bexarotene 1% Top Gel
Drug: Nitrogen Mustard

First Posted Date: 2021-11-03

Last Posted Date: 2025-01-06

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 22

Registration Number: NCT05106192

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures

Not Applicable

Withdrawn

Conditions: Hematologic Diseases

Interventions: Other: Placebo oil
Other: Lavender Oil Aromatherapy
Procedure: BMAB procedure

First Posted Date: 2021-11-01

Last Posted Date: 2021-11-10

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT05102331

Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

Completed

Conditions: Stage III Melanoma
Stage IV Cutaneous Melanoma

First Posted Date: 2021-10-15

Last Posted Date: 2024-07-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 73

Registration Number: NCT05079113

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer center, Cleveland, Ohio, United States

The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction

Not Applicable

Terminated

Conditions: Breast Reconstruction

Interventions: Procedure: Delayed autologous breast reconstruction
Behavioral: Perioperative Functional Medicine (FM) Care

First Posted Date: 2021-08-31

Last Posted Date: 2024-06-21

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT05028101

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy